COVID-19: what you need to know about the coronavirus pandemic on November 16 – Community News
Covid-19

COVID-19: what you need to know about the coronavirus pandemic on November 16

  • This daily news feed provides you with a selection of the latest news and updates on the COVID-19 coronavirus pandemic, as well as tips and resources to help you stay informed and protected.
  • Top Stories: Czech Republic Records Fifth Day of Business Above 10,000; Nigeria plans massive vaccination campaign; AstraZeneca has delivered two billion vaccine doses of COVID-19.

1. How COVID-19 Is Affecting the World

According to Johns Hopkins University, the global 253.9 million confirmed cases of COVID-19 have passed. The number of confirmed deaths has now passed 5.1 million. More than 7.54 billion doses of vaccines have been administered worldwide, according to Our World in Data.

The Czech Republic reported 11,514 new COVID-19 cases for Nov. 15, the fifth time the daily number of infections has surpassed 10,000 in the past seven days, data from the health ministry showed on Tuesday.

It came as the US Centers for Disease Control and Prevention advised against traveling to the Czech Republic, Hungary and Iceland due to the rising number of COVID-19 cases in those countries.

China administered about 6.5 million doses of COVID-19 vaccines on Nov. 15, bringing the total to 2.396 billion, data from the National Health Commission showed on Tuesday. It also reported 22 new confirmed cases of coronavirus for Nov. 15, compared with 52 a day earlier, the health authority said.

Mexico’s health ministry on Monday reported 775 new confirmed cases of coronavirus and 57 more fatalities, bringing the country’s total death toll from the pandemic to 291,204 and its total number of cases to 3,846,508.

Russia will lift the COVID-19 ban on flights to countries such as Bangladesh, Brazil, Mongolia, Costa Rica and Argentina from Dec. 1, the government’s coronavirus task force said on Tuesday.

Russia has also approved Pfizer Inc to conduct clinical trials of its experimental antiviral pill to treat COVID-19 in the country, a state registry of drugs found.

A ban on public sector workers from entering their offices if they have not been vaccinated and tested for COVID-19 came into effect in Egypt on Monday, as the government urges to accelerate vaccination coverage in the final weeks of the outbreak. year.

2. Nigeria plans massive vaccination campaign

Nigeria will launch a massive COVID-19 vaccination campaign later this week, aiming to vaccinate half of its target population by the end of January, government officials said.

Africa’s most populous country aims to vaccinate 111 million people to achieve herd immunity.

Under the initiative, which kicks off Friday, 55 million doses or more than a million per day will be administered. To date, the country has vaccinated only 2.9% of those eligible for vaccines.

The plan will include setting up vaccine sites at private health facilities, universities, colleges, stadiums, motorcycle parks and shopping malls.

Boss Mustapha, head of the presidential steering committee for COVID-19, said the government has “enough vaccines in the pipeline to vaccinate about 50% of the target population by the end of January 2022”.

New confirmed COVID-19 cases per million people daily.

Daily new confirmed COVID-19 cases per million people in selected countries.

Image: Our world in data

3. AstraZeneca COVID-19 Vaccine Supply Reaches Two Billion Doses

Two billion doses of the AstraZeneca-Oxford University COVID-19 vaccine have been delivered worldwide, the Anglo-Swedish drugmaker and its partner said Tuesday, in just under a year since its first approval.

The injection, which is the largest contributor to the World Health Organization-backed COVAX vaccination program, is being made in 15 countries for delivery to more than 170 countries, London-based AstraZeneca and the University of Oxford said in a joint statement.

AstraZeneca signed in June last year with the Indian Serum Institute, the world’s largest manufacturer of vaccines by volume, to help double the vaccine’s production capacity to two billion doses.

In 2000, Gavi, the Vaccine Alliance was launched at the World Economic Forum’s annual meeting in Davos, with an initial pledge of $750 million from the Bill and Melinda Gates Foundation.

Gavi’s goal is to make vaccines more accessible and affordable for everyone, anywhere in the world.

In addition to saving an estimated 10 million lives worldwide in less than 20 years by vaccinating nearly 700 million children, Gavi recently delivered a life-saving vaccine against Ebola.


At Davos 2016, we announced Gavi’s partnership with Merck to realize the life-saving Ebola vaccine.

The Ebola vaccine is the result of years of energy and commitment from Merck; the generosity of the Federal Government of Canada; leadership by the WHO; strong support for vaccine testing from both NGOs such as MSF and the countries affected by the outbreak in West Africa; and the prompt response and dedication of the DRC Minister of Health. Without these efforts, it is unlikely that this vaccine would be available for several years, if at all.

Learn more about the Vaccine Alliance and how you can help improve access to vaccines worldwide – in our Impact Story.

The vaccine has faced challenges in efficacy data, supplies and links to rare blood clots.

AstraZeneca said last week that if the world learns to live with the coronavirus that causes COVID-19, it would start making a modest profit from the injection after committing to sell it at cost during the pandemic.

However, the company’s chief executive officer, Pascal Soriot, assured that low-income countries would continue to receive nonprofit vaccines.

About the author

Rakesh

Add Comment

Click here to post a comment